Published in J Womens Health (Larchmt) on December 01, 2014
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction. F1000Prime Rep (2015) 0.82
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. Nat Commun (2017) 0.79
Structural basis for KCNE3 modulation of potassium recycling in epithelia. Sci Adv (2016) 0.76
Characterization and small-molecule stabilization of the multisite tandem binding between 14-3-3 and the R domain of CFTR. Proc Natl Acad Sci U S A (2016) 0.76
The effects of inhaled aztreonam on the cystic fibrosis lung microbiome. Microbiome (2017) 0.76
Gender, Estrogen, and Obliterative Lesions in the Lung. Int J Endocrinol (2017) 0.75
End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis. Respir Res (2017) 0.75
Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports. Respir Med Case Rep (2017) 0.75
Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis. Clin Drug Investig (2017) 0.75
Nationwide trends of hospitalizations for cystic fibrosis in the United States from 2003 to 2013. Intractable Rare Dis Res (2017) 0.75
17β-estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism. Infect Immun (2017) 0.75
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med (2011) 8.73
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23
The changing epidemiology of cystic fibrosis. J Pediatr (1993) 5.50
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med (2008) 4.33
Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol (2001) 4.12
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J (2003) 4.08
Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest (2009) 4.08
Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80
Gender gap in cystic fibrosis mortality. Am J Epidemiol (1997) 2.74
A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J (2007) 2.53
Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care (2010) 2.52
Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol (1996) 2.28
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med (2014) 2.25
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol (1995) 2.11
Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med (2012) 1.93
Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA (2010) 1.69
Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol (2003) 1.62
Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax (2011) 1.46
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med (2010) 1.33
17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest (2008) 1.32
Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol (2007) 1.28
Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest (2006) 1.27
Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care (2009) 1.22
Effect of oestrogen on Mycobacterium avium complex pulmonary infection in mice. Clin Exp Immunol (2001) 1.18
Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med (2010) 1.18
Is there still a gender gap in cystic fibrosis? Chest (2005) 1.16
Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis (2013) 1.12
Effects of the menstrual cycle on lung function variables in women with asthma. Am J Respir Crit Care Med (2009) 1.10
17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor. Am J Respir Crit Care Med (2010) 1.08
Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res (2010) 1.03
Incidence trends and gender differences in malignant mesothelioma in New South Wales, Australia. Scand J Work Environ Health (2007) 1.02
Bronchiectasis: sex and gender considerations. Clin Chest Med (2004) 1.01
Sex hormone-dependent regulation of cilia beat frequency in airway epithelium. Am J Respir Cell Mol Biol (2011) 0.98
Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretion. J Pharmacol Exp Ther (2000) 0.93
Impact of age and gender on adherence to infection control guidelines and medical regimens in cystic fibrosis. Pediatr Pulmonol (2010) 0.93
Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years. Am J Epidemiol (2002) 0.91
Are measures of body habitus associated with mortality in cystic fibrosis? Chest (2012) 0.87
Sex hormones regulate CFTR in developing fetal rat lung epithelial cells. Am J Physiol (1997) 0.81
Immune, inflammatory and infectious consequences of estrogen in women with cystic fibrosis. Expert Rev Respir Med (2012) 0.80
Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men. Pediatr Pulmonol (2013) 0.80
Optimizing treatments for lymphangioleiomyomatosis. Expert Rev Respir Med (2012) 0.79
Absence of a gender gap in survival. An analysis of the Italian registry for cystic fibrosis in the paediatric age. J Cyst Fibros (2011) 0.79
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax (2011) 2.84
Predictors of failed primary abdominal closure in the trauma patient with an open abdomen. South Med J (2013) 1.39
FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin. J Appl Physiol (1985) (2006) 1.38
Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect (2006) 1.36
Is hypothermia simply a marker of shock and injury severity or an independent risk factor for mortality in trauma patients? Analysis of a large national trauma registry. J Trauma (2005) 1.32
Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med (2006) 1.16
Ethnic disparities exist in trauma care. J Trauma (2007) 1.10
Systemic hypotension is a late marker of shock after trauma: a validation study of Advanced Trauma Life Support principles in a large national sample. Am J Surg (2006) 1.09
[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation. Am J Respir Crit Care Med (2009) 1.07
When policy meets statistics: the very real effect that questionable statistical analysis has on limiting health care access for bariatric surgery. Arch Surg (2007) 0.98
Higher-order reasoning training years after traumatic brain injury in adults. J Head Trauma Rehabil (2011) 0.89
Prediction of pulmonary morbidity and mortality in patients with femur fracture. J Trauma (2010) 0.87
Effect of trauma systems on motor vehicle occupant mortality: A comparison between states with and without a formal system. J Trauma (2006) 0.82
Altered mental status in cirrhosis: etiologies and outcomes. J Investig Med (2013) 0.80
Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men. Pediatr Pulmonol (2013) 0.80
Injury severity and comorbidities alone do not predict futility of care after geriatric trauma. J Palliat Med (2014) 0.80
Severe hypoglycemia associated with use of trimethoprim/sulfamethoxazole in a patient with chronic renal insufficiency. Ann Pharmacother (2008) 0.79
Creation and use of a database in clinical and translational research. J Investig Med (2010) 0.79
Interrater reliability of needle electromyographic findings in lumbar radiculopathy. Am J Phys Med Rehabil (2010) 0.77
Pulmonary hyalinizing granuloma associated with Aspergillus infection. Int J Surg Pathol (2003) 0.77
Upregulation of elastin expression in constrictive bronchiolitis obliterans. Int J Chron Obstruct Pulmon Dis (2007) 0.77
Needle electromyography predicts outcome after lumbar epidural steroid injection. Muscle Nerve (2012) 0.77
1614: TENSION PNEUMOTHORAX PRESENTING WITH ST SEGMENT ELEVATION. Crit Care Med (2016) 0.75
Cavitary lung nodules in a patient with prior squamous cell carcinoma of the submandibular gland. Am J Respir Crit Care Med (2014) 0.75